George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.50
Bid: 103.00
Ask: 108.00
Change: -0.50 (-0.47%)
Spread: 5.00 (4.854%)
Open: 105.50
High: 105.00
Low: 105.00
Prev. Close: 105.50
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

21 Sep 2023 13:31

RNS Number : 2562N
Intercede Group PLC
21 September 2023
 

21 September 2023 Intercede Group PLC

("Intercede", "the Company" or the "Group'') 

Result of AGM

 

Intercede, the leading specialist in digital identity, credential management and secure mobility, is pleased to announce that at its Annual General Meeting held early today, all resolutions were duly passed. Resolutions 1 to 9 were passed as ordinary resolutions and resolutions 10 to 13 were passed as special resolutions.

 

Ordinary Business

% Voted

Yes

1. To receive and to adopt the Company's financial statements for the year ended 31 March 2023 together with the reports of the Directors and the auditors.

86.88

2. To re-elect R Hoggarth as a director.

95.67

3. To re-elect J Tredoux as a director.

83.09

4. To re-elect K van der Leest as a director.

99.92

5. To re-elect N Patel as a director.

99.92

6. To re-elect T Whitley as a director.

99.92

7. To appoint John Linwood as a director.

99.92

8. To appoint Cooper Parry Ltd to hold office as auditors until the next Annual General Meeting, and to authorise the Directors to determine the remuneration of the auditors.

100.00

 Special Business

9. To renew the authority given to the Directors to generally and unconditionally allot new securities in accordance with section 551 of the Companies Act 2006 (the "Act"), within the parameters set out in the Notice (as defined in the Notes below).

99.92

10. That the Directors be given power (subject to the passing of resolution 9) (i) to allot for cash equity securities (as defined in section 560(1) of the Act for the purposes of section 561 of the Act) and (ii) to allot equity securities (as defined in section 560(2) of the Act, in either case as if section 561(1) of the Act did not apply to the allotment, within the parameters set out in the Notice.

99.83

11. That the Directors be given power (subject to the passing of resolution 9) to allot for cash equity securities (as defined in section 560 of the Act for the purposes of section 561 of the Act) as if section 561(1) of the Act did not apply to any such allotment, within the parameters set out in the Notice.

99.83

12. That, in accordance with article 10 of the Company's articles of association and the Act, the Company is generally and unconditionally authorised to make market purchases (within the meaning of section 693 of the Act) of ordinary shares of 1 pence each in the capital of the Company (Ordinary Shares). within the parameters set out in the Notice.

99.96

13. That with effect from the conclusion of the meeting, article 97.1 of the Articles of Association of the Company be amended as further set out in the Notice.

99.93

 

Change of Name of Nominated Adviser and Broker

 

The Company also announces that its Nominated Adviser and Broker has changed its name to Cavendish Capital Markets Limited following completion of its own corporate merger.

 

ENQUIRIES

Intercede Group plc

Tel. + 44 (0)1455 558111

Klaas van der Leest

CEO

Nitil Patel

CFO

 

 

 

 

Cavendish Capital Markets Limited

Tel. + 44 (0)20 7220 0500

Simon Hicks/Fergus Sullivan

Corporate Finance

Tim Redfern/Charlotte Sutcliffe

ECM

 

Notes

The full text of the resolutions passed at the AGM can be found in the Notice of Annual General Meeting (the "Notice") which is attached to the Annual Report and is available on the Investors section of the Company's website: RNS - AGM Notice and Publication of Annual Report and Accounts - Intercede

About Intercede

Intercede is a cybersecurity company specialising in digital identities, derived credentials and access control, enabling digital trust in a mobile world. Headquartered in the UK, with offices in the US, we believe in a connected world in which people and technology are free to exchange information securely, and complex insecure passwords become a thing of the past.

Our vision is to make the highest levels of cybersecurity available to organisations and consumers alike, solving complexity and scalability issues by managing high volumes of digital credentials.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSESFEFEDSEDU
Date   Source Headline
26th Apr 202410:02 amRNSShare Incentive Scheme
23rd Apr 20247:00 amRNSCapital Markets Day
8th Apr 20247:00 amRNSTrading Update
2nd Apr 20247:00 amRNSContract and Subscription Renewals
25th Mar 20243:38 pmRNSHolding(s) in Company
25th Mar 20243:35 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSNew Orders and Trading Update
21st Mar 20247:00 amRNSNew Product Announcement: Launch of MyID MFA v5
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
29th Jan 20247:00 amRNSNew Orders
18th Jan 20249:55 amRNSDirector/PDMR Shareholding
3rd Jan 20247:00 amRNSMajor New Contract Win
7th Dec 20237:00 amRNSUpdate on Major New Contract Win
5th Dec 202312:30 pmRNSMajor New Contract with Large US Federal Agency
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding
21st Nov 20237:01 amRNSNew Contract and Renewal Orders
21st Nov 20237:00 amRNSHalf-year Report
7th Nov 20237:00 amRNSContract and Renewals Orders
25th Oct 20234:44 pmRNSDirector/PDMR Shareholding
24th Oct 20237:00 amRNSNotice of Interim Results & Investor Presentation
20th Oct 20237:03 amRNSAppointment of Non-Executive Director
11th Oct 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20237:00 amRNSTrading Update
21st Sep 20231:31 pmRNSResult of AGM
4th Sep 20237:00 amRNSContract and Renewals Orders
30th Aug 20237:10 amRNSNotice of AGM and Publication of Annual Report
20th Jun 20237:01 amRNSBoard Changes
20th Jun 20237:00 amRNSFinal Results
12th Jun 20237:00 amRNSNotice of Results & Investor Presentation
27th Apr 20237:00 amRNSShare Incentive Plan
17th Apr 20237:00 amRNSTrading Update
3rd Apr 20237:00 amRNSContract wins/renewals
3rd Feb 202310:46 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSChange of Auditors
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
23rd Jan 20232:00 pmRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSTrading Update
11th Jan 20232:30 pmRNSDirector/PDMR Shareholding
2nd Dec 20228:45 amRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSHalf-year Report
11th Nov 20227:00 amRNSNotice of Interim Results & Investor Presentation
13th Oct 202210:30 amRNSDirector/PDMR Shareholding
11th Oct 20221:00 pmRNSDirector/PDMR Shareholding
10th Oct 20228:00 amRNSLong Term Incentive Plan
10th Oct 20227:01 amRNSAcquisition of Authlogics Ltd
10th Oct 20227:00 amRNSTrading Update
28th Sep 202212:22 pmRNSResult of AGM
15th Sep 20227:00 amRNSDirector/PDMR Shareholding and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.